Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.9%

13 terminated/withdrawn out of 452 trials

Success Rate

92.0%

+5.5% vs industry average

Late-Stage Pipeline

17%

78 trials in Phase 3/4

Results Transparency

2%

3 of 150 completed trials have results

Key Signals

41 recruiting3 with results9 terminated4 withdrawn

Enrollment Performance

Analytics

N/A
172(54.3%)
Phase 4
57(18.0%)
Phase 2
46(14.5%)
Phase 3
21(6.6%)
Phase 1
20(6.3%)
Early Phase 1
1(0.3%)
317Total
N/A(172)
Phase 4(57)
Phase 2(46)
Phase 3(21)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (452)

Showing 20 of 452 trials
NCT07562100Not ApplicableRecruiting

Develop and Evaluate An Artificial Intelligence Assisted Prehabilitation Program for Returning to Work and Cost-effectiveness Analysis in Patients With Oral Cancer

Role: lead

NCT06461780Recruiting

Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy

Role: lead

NCT07400757Not ApplicableRecruiting

Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease

Role: lead

NCT07543328Not ApplicableRecruiting

Transcranial Photobiomodulation (tPBM) for Somatic Symptoms in Treatment-Resistant Depression

Role: lead

NCT07543354Not ApplicableNot Yet Recruiting

Personalized Therapy of Long-term Low FODMAP in IBS Treatment: Role of Mobile Application and "Microbiota-gut-brain" Axis

Role: lead

NCT07536373Phase 3Not Yet Recruiting

Colchicine in Chronic Limb-Threatening Ischemia

Role: collaborator

NCT04180072Not ApplicableActive Not Recruiting

Atezolizumab Plus Bevacizumab With HCC and HBV Infection

Role: collaborator

NCT05927857Phase 1Recruiting

Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .

Role: collaborator

NCT05048901Phase 1Recruiting

Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors

Role: collaborator

NCT05805631Phase 2Recruiting

Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC

Role: lead

NCT07479147Recruiting

SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation

Role: collaborator

NCT05800509Not ApplicableRecruiting

Gestational Diabetes and Perinatal Depression: an Intervention Program

Role: collaborator

NCT07473687Recruiting

Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room

Role: lead

NCT07463443Not ApplicableNot Yet Recruiting

Effectiveness of Chatbot for Improving Caregiving Outcomes in Primary Caregivers of Geriatric Pneumonia Patients: A Study on Knowledge, Attitude and Practice.

Role: lead

NCT07438132Completed

The Validation of the Identification System of Fiber-optic Probe Optical Coherent Tomography Assisted Pneumoperitoneum Creation

Role: lead

NCT05875870Not ApplicableRecruiting

Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer

Role: lead

NCT07362134Not ApplicableEnrolling By Invitation

Pulsed-Field Ablation for Recurrent Atypical Atrial Flutter

Role: lead

NCT07179848Phase 1Recruiting

Safety and Feasibility of Temporal Interference Brain Stimulation for Treatment in Psychiatric Disorders

Role: lead

NCT07369791Phase 2Not Yet Recruiting

Nivolumab Plus Relatlimab and Gemcitabine/Cisplatin as First-Line Treatment in Advanced Biliary Tract Cancer.

Role: collaborator

NCT07362147Not ApplicableNot Yet Recruiting

Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life

Role: lead